Wildeman, Maarten A <br/><br/>
Cytolytic virus activation therapy for Epstein-Barr virus-driven tumors.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Sep 2012 
 - 5061-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-0574  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Viral--blood<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Carcinoma<br/>Cell Line, Tumor<br/>DNA, Viral--genetics<br/>Deoxycytidine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Herpesvirus 4, Human--drug effects<br/>Humans<br/>Immunoglobulin G--blood<br/>Male<br/>Middle Aged<br/>Nasopharyngeal Carcinoma<br/>Nasopharyngeal Neoplasms--drug therapy<br/>Neoplasm Staging<br/>Treatment Outcome<br/>Valproic Acid--administration & dosage<br/>Viral Load<br/>Virus Activation--drug effects<br/>Gemcitabine